Our analysis of human tumor data showed that over 75% of RIT1-altered lung adenocarcinomas harbor co-occurring loss of expression of at least one Hippo pathway gene, and we verified high rates of YAP1 nuclear staining in an independent RIT1-mutant tumor cohort. The gene discussed is RIT1; the disease is lung adenocarcinoma.